2024-04-26  5:19:51 PM Chg. -0.69 Volume Bid5:20:00 PM Ask5:20:00 PM Market Capitalization Dividend Y. P/E Ratio
30.04CHF -2.23% 299,641
Turnover: 8.99 mill.
-Bid Size: - -Ask Size: - 13.6 bill.CHF - -

Business description

Sandoz is a global leader in off-patent medicines, based on our strong scientific heritage. Our purpose is to pioneer access for patients. We focus on driving access to make a difference for patients, working always with patients in mind.
 

Management board & Supervisory board

CEO
-
Management board
-
Supervisory board
-
 

Company data

Name: Sandoz Group N
Address: Forum 1 Novartis Campus CH-4056,Basel
Phone: +41 61 324 11 11
Fax: +41 61 324 11 11
E-mail: -
Internet: https://www.sandoz.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12-31
Free Float: -
IPO date: 2023-10-04

Investor relations

Name: Karen King
IR phone: -
IR Fax: -
IR e-mail: investor.relations@sandoz.com

Company calendar

CW 18 | 2024-04-30 General Shareholder Meeting
CW 18 | 2024-05-03 Ex-Dividend
CW 19 | 2024-05-06 Record Date
CW 19 | 2024-05-07 Dividend Payment
CW 19 | 2024-05-07 Interim Report 1st Quarter/3 Months
 

Main Shareholders